Unusually Long Survival of a 67-Year-Old Patient with Near-Tetraploid Acute Myeloid Leukemia M0 without Erythroblastic and Megakaryocytic Dysplasia
暂无分享,去创建一个
J. Jelinek | H. Klamová | Z. Zemanová | J. Březinová | K. Michalová | I. Marinov | J. Schwarz | O. Fuchs | J. Marková | P. Lemež | A. Kostečka | D. Provazníková
[1] K. Anderson,et al. Genetic variegation of clonal architecture and propagating cells in leukaemia , 2011, Nature.
[2] James R. Downing,et al. Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells , 2010, Nature.
[3] A. Chapelle,et al. Polyploidy of the bone marrow. , 2009 .
[4] J. Starý,et al. Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome , 2009, Leukemia & lymphoma.
[5] J. Merker,et al. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system. , 2008, Blood.
[6] M. Caligiuri,et al. Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] C. Preudhomme,et al. Prognostic value of dysmyelopoietic features in de novo acute myeloid leukaemia: a report on 132 patients. , 2008, Clinical and laboratory haematology.
[8] H. Klamová,et al. CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma. , 2008, Blood cells, molecules & diseases.
[9] M. Balbín,et al. A new type of NPM1 gene mutation in AML leading to a C-terminal truncated protein , 2007, Leukemia.
[10] K. Döhner,et al. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. , 2006, Blood.
[11] T. Haferlach,et al. Near-tetraploid acute myeloid leukemias: an EGIL retrospective study of 25 cases , 2006, Leukemia.
[12] M. Caligiuri,et al. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Sandya Liyanarachchi,et al. Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] T. Haas,et al. Erythroblastic and/or megakaryocytic dysplasia in de novo acute myeloid leukemias M0-M5 show relation to myelodysplastic syndromes and delimit two main categories. , 2000, Leukemia research.
[15] J. Jelinek,et al. Three cases of near-tetraploid acute myeloid leukemias originating in pluripotent myeloid progenitors. , 1998, Leukemia research.
[16] Secker-Walker,et al. Trisomy 13 and myeloid malignancy — characteristic blast cell morphology: a United Kingdom Cancer Cytogenetics Group survey , 1998, British journal of haematology.
[17] M. Caligiuri,et al. Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. , 1996, Cancer research.
[18] L. Contis,et al. Near-tetraploidy in adult acute myelogenous leukemia. , 1996, Cancer genetics and cytogenetics.
[19] P. Greenberg,et al. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. , 1994, Blood.
[20] A. Jirásek,et al. Near-tetraploid poorly differentiated acute myeloid leukemia M0 diagnosed by short-term cultures with a phorbol ester TPA. , 1994, Leukemia research.
[21] H. Gralnick,et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO) , 1991, British journal of haematology.
[22] D. Catovsky,et al. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia , 1987, British journal of haematology.
[23] H. Gralnick,et al. Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.
[24] Z. Zemanová,et al. [Patients older than 80 years with de novo acute myeloid leukemias without erythroblastic and/or megakaryocytic dysplasia achieve complete remission and longer survival after classical chemotherapy 3 + 7]. , 2010, Vnitrni lekarstvi.
[25] H. Qiu,et al. Tetraploid clone characterized by two t(15;17) in five cases of acute promyelocytic leukemia. , 2009, Cancer genetics and cytogenetics.
[26] K. Michalová,et al. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia. , 2007, Neoplasma.
[27] S. Matsui,et al. Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome. , 2004, Cancer genetics and cytogenetics.
[28] M. Yao,et al. Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23 , 2002, Leukemia.
[29] P. Greenberg,et al. Expression of EVIl in Myelodysplastic Syndromes and Other Hematologic Malignancies Without 3 q 26 Translocations , 2002 .
[30] T. Haas,et al. Do de novo acute myeloid leukemias with normal cytogenetics involve two main prognostic categories distinguished by the presence of erythroblastic and/or megakaryocytic dysplasia? , 2000, Neoplasma.
[31] Iscn. International System for Human Cytogenetic Nomenclature , 1978 .